共 8 条
[1]
for the Program on the Sur-gical Control of Hyperlipidemias (POSCH)Group: Changes in sequen-tial coranary arteriograms and subsequent coronary events. Buchwald H,Matts JP,Fitch LL,et al. The Journal of The American Medical Association . 1992
[2]
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian survival study(4s). The Scandinavian Simvastatin Survival Study Group. The Lancet . 1994
[3]
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. Sacks FM,Pfeffer MA,Moye LA,et al. New England Journal of Homeopathy . 1996
[4]
Second report of the expert pan-el on detection, evaluation, and treatment of high blood cholesterol inadults (Adult Treatment Panel Ⅱ). National Cholesterol Education Program. Circulation . 1994
[5]
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study Group. New England Journal of Medicine, The . 1998
[6]
For the West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. Shepherd J,Cobbe SM,Ford I,et al. New England Journal of Homeopathy . 1995
[7]
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Downs J R,Clearfield M,Weis S,et al. The Journal of The American Medical Association . 1998
[8]
Reduction in mortlity in Stockholm Is-chemic Heart Disease Secondary Prevention Study by combined treat-ment with clofibrate and nicotinic acid. Carlson LA,Rosenhamer G. Acta Medica Scandinavica . 1988